首页> 外文期刊>Experimental Lung Research >The impact of sodium aescinate on acute lung injury induced by oleic acid in rats
【24h】

The impact of sodium aescinate on acute lung injury induced by oleic acid in rats

机译:七叶皂苷钠对油酸致大鼠急性肺损伤的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are associated with high rates of morbidity and mortality. Currently, several surfactant or anti-inflammatory drugs are under test as treatments for ALI. Sodium aescinate (SA) has been shown to exert anti-inflammatory and antiedematous effects. In the present work, the authors explored the effects of SA and the possible mechanisms of SA action in rats with ALI induced by oleic acid (OA) administration. Eight groups of rats received infusions of normal saline (NS) or OA. Rats exposed to OA were pretreated with 1 mg/kg of SA, or posttreated with SA at low (1 mg/kg), medium (2 mg/kg), or high (6 mg/kg) dose; a positive-control group received methylprednisolone. The pressure of oxygen in arterial blood (Po2) levels, the pulmonary wet/dry weight (W/D) ratios, and indices of quantitative assessment (IQA) of histological lung injury were obtained 2 or 6 hours after OA injection (0.1 mL/kg, intravenously). The levels of superoxide dismutase (SOD), malondialdehyde (MDA), matrix metalloproteinase gelatinase B (MMP-9), and tissue inhibitor of metalloproteinase (TIMP-1) in both plasma and lung tissue were also determined. Both pre- and posttreatment with SA improved OA-induced pulmonary injury, increased Po2 and SOD values, lowered IQA scores, and decreased the lung W/D ratio and MDA and MMP-9 levels in plasma and lung tissue. SA appeared to abrogate OA-induced ALI by modulating the levels of SOD, MDA, and MMP-9 in plasma and lung tissue.
机译:急性肺损伤(ALI)和急性呼吸窘迫综合征(ARDS)与高发病率和高死亡率相关。当前,几种表面活性剂或抗炎药正在测试中作为ALI的治疗方法。七叶皂苷钠(SA)已显示出抗炎和抗水肿的作用。在目前的工作中,作者探索了油酸(OA)诱导的ALI大鼠ALI中SA的作用及其SA作用的可能机制。八组大鼠接受了生理盐水(NS)或OA的输注。暴露于OA的大鼠接受1 mg / kg的SA预处理,或以低剂量(1 mg / kg),中度(2 mg / kg)或高剂量(6 mg / kg)进行SA后处理;阳性对照组接受甲基泼尼松龙治疗。在注射OA(0.1 mL / ml)后2或6小时获得动脉血中的氧气压力(Po2)水平,肺干/湿重(W / D)比以及组织学肺损伤的定量评估指数(IQA)。公斤,静脉注射)。还测定了血浆和肺组织中的超氧化物歧化酶(SOD),丙二醛(MDA),基质金属蛋白酶明胶酶B(MMP-9)和金属蛋白酶组织抑制剂(TIMP-1)的水平。 SA的治疗前后均改善了OA引起的肺损伤,增加了PO2和SOD值,降低了IQA评分,并降低了血浆和肺组织中的肺W / D比以及MDA和MMP-9水平。 SA似乎可以通过调节血浆和肺组织中的SOD,MDA和MMP-9含量来消除OA诱导的ALI。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号